Anti‐monocyte chemoattractant protein‐1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The FASEB Journal

• Publication date

  2002-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1096/fj.02-0094fjePMID 12223446
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting CCR2 or CD18 Inhibits Experimental In-Stent Restenosis in Primates: Inhibitory Potential Depends on Type of Injury and Leukocytes Targeted

  2002cited by this paper
• Real-Time Quantitative PCR

  2002cited by this paper
• New Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Atherosclerosis in Apolipoprotein E-Knockout Mice

  2001cited by this paper
• Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Restenosis After Coronary Angioplasty

  2001cited by this paper
• Chemokines and disease

  2001cited by this paper
• Atherosclerosis The Road Ahead

  2001cited by this paper
• Anti‐monocyte chemoattractant protein‐1 gene therapy inhibits vascular remodeling in rats: blockade of MCP‐1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis

  2000cited by this paper
• Roles of P-Selectin in Inflammation, Neointimal Formation, and Vascular Remodeling in Balloon-Injured Rat Carotid Arteries

  2000cited by this paper
• Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats.

  2000cited by this paper
• Role of Monocyte Chemoattractant Protein-1 in Cardiovascular Remodeling Induced by Chronic Blockade of Nitric Oxide Synthesis

  2000cited by this paper
• Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats.

  2000cited by this paper
• Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries.

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Frontiers in interventional cardiology.

  1998cited by this paper
• Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

  1998cited by this paper
• Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.

  1998cited by this paper
• Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions.

  1998cited by this paper
• Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.

  1997cited by this paper
• Restenosis revisited--new targets, new therapies.

  1997cited by this paper
• Real time quantitative PCR.

  1996cited by this paper
• Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody.

  1993cited by this paper
• JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells.

  1992cited by this paper
• Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.

  1991cited by this paper
• Restenosis After Coronary Angioplasty: Potential Biologic Determinants and Role of Intimal Hyperplasia

  1989cited by this paper

• Antagonizing CCR2 With Propagermanium Leads to Altered Distribution of Macrophage Subsets and Favorable Tissue Remodeling After Myocardial Infarction in Mice

  2025cites this paper
• A CCL2/MCP-1 antagonist attenuates fibrosis of the infrapatellar fat pad in a rat model of arthritis

  2024cites this paper
• Value of M2BP in predicting in‐stent restenosis in patients after coronary drug‐eluting stent implantation

  2022cites this paper
• Nanoplastic-induced vascular endothelial injury and coagulation dysfunction in mice.

  2022cites this paper
• Macrophage-HIF1α signaling in carotid artery stenosis.

  2021cites this paper
• Viromers as carriers for mRNA-mediated expression of therapeutic molecules under inflammatory conditions

  2020cites this paper
• In vitro study of human endothelial progenitor cells behaviour on nitrided Ni-free Ti–27Nb alloy

  2019cites this paper
• MCP-1 mediates ischemia/reperfusion-induced cardiomyocyte apoptosis via MCPIP1 and CaSR.

  2019cites this paper
• Local delivery of thalidomide to inhibit neointima formation in rat model with artery injury.

  2018cites this paper
• Chemokines in atherosclerosis 715 Endothelial dysfunction triggers migration of inflammatory cells

  2017cites this paper
• Induced Pluripotent Stem Cell‐Derived Endothelial Cells Overexpressing Interleukin‐8 Receptors A/B and/or C‐C Chemokine Receptors 2/5 Inhibit Vascular Injury Response

  2017cites this paper
• An assessment of the use of the ABSORB bioresorbable vascular scaffold in the treatment of 'false' coronary bifurcations

  2017cites this paper
• Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease.

  2017cites this paper
• Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell‐Derived Chemokine (C‐C Motif) Ligand 2 and Chemokine (C‐X‐C motif) Ligand 1 Contributes to Neointima Formation

  2016cites this paper
• Nickel ions from a corroded cardiovascular stent induce monocytic cell apoptosis: Proposed impact on vascular remodeling and mechanism.

  2015cites this paper
• Dynamic Interplay Between Smooth Muscle Cells and Macrophages in Vascular Disease

  2015cites this paper
• Pitavastatin-incorporated nanoparticle-eluting stents attenuate in-stent stenosis without delayed endothelial healing effects in a porcine coronary artery model.

  2013cites this paper
• Gene delivery strategies targeting stable atheromatous plaque.

  2013cites this paper
• Crosstalk between macrophages and smooth muscle cells in atherosclerotic vascular diseases.

  2012cites this paper
• A truncated analogue of CCL2 mediates anti-fibrotic effects on murine fibroblasts independently of CCR2.

  2012cites this paper
• Aldosterone-induced osteopontin expression in vascular smooth muscle cells involves MR, ERK, and p38 MAPK

  2012cites this paper
• Gene therapy targeting inflammation in atherosclerosis.

  2011cites this paper
• TRAIL promotes caspase-dependent pro-inflammatory responses via PKCδ activation by vascular smooth muscle cells

  2011cites this paper
• Imatinib mesylate-incorporated nanoparticle-eluting stent attenuates in-stent neointimal formation in porcine coronary arteries.

  2011cites this paper
• Anti-inflammatory gene therapy for cardiovascular disease.

  2011cites this paper
• The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions

  2011cites this paper
• Curcumin inhibits ox-LDL-induced MCP-1 expression by suppressing the p38MAPK and NF-κB pathways in rat vascular smooth muscle cells

  2011cites this paper
• Therapeutic implications of chemokine-mediated pathways in atherosclerosis: realistic perspectives and utopias

  2010cites this paper
• Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases

  2010cites this paper
• Discovery of (Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione, a readily available and orally active glitazone for the treatment of concanavalin A-induced acute liver injury of BALB/c mice.

  2010cites this paper
• Serum profiles of monocyte chemoattractant protein-1 as a biomarker for patients recovering from myocardial infarction

  2010cites this paper
• A new monocyte chemotactic protein-1/chemokine CC motif ligand-2 competitor limiting neointima formation and myocardial ischemia/reperfusion injury in mice.

  2010cites this paper
• A novel antioxidant 3,7-dihydroxy-isoflav-3-ene (DHIF) inhibits neointimal hyperplasia after vessel injury attenuating reactive oxygen species and nuclear factor-kappaB signaling.

  2009cites this paper
• Nanoparticle-Mediated Delivery of Nuclear Factor &kgr;B Decoy Into Lungs Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension

  2009cites this paper
• New molecular strategies for prevention of fibroproliferative vascular disease : An experimental approach to restenosis

  2009cites this paper
• A critical role of COX-2 in the progression of neointimal formation after wire injury in mice

  2009cites this paper
• Integrative Physiology/Experimental Medicine Soluble Flt-1 Gene Transfer Ameliorates Neointima Formation After Wire Injury in flt-1 Tyrosine Kinase–Deficient Mice

  2009cites this paper
• Inflammation in injury-induced vascular remodelling : functional involvement and therapeutical options

  2008cites this paper
• Local Delivery of Imatinib Mesylate (STI571)–Incorporated Nanoparticle Ex Vivo Suppresses Vein Graft Neointima Formation

  2008cites this paper
• Angiotensin II−Induced Osteopontin Expression in Vascular Smooth Muscle Cells Involves Gq/11, Ras, ERK, Src and Ets-1

  2008cites this paper
• CCR2-Mediated Antiinflammatory Effects of Endothelial Tetrahydrobiopterin Inhibit Vascular Injury–Induced Accelerated Atherosclerosis

  2008cites this paper
• Experimental models investigating the inflammatory basis of atherosclerosis

  2008cites this paper
• Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeys.

  2007cites this paper
• Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker?

  2007cites this paper
• Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.

  2007cites this paper
• Local Delivery of Anti-Monocyte Chemoattractant Protein-1 by Gene-Eluting Stents Attenuates In-Stent Stenosis in Rabbits and Monkeys

  2007cites this paper
• The specific role of chemokines in atherosclerosis

  2007cites this paper
• The peptide analogue of MCP-1 65-76 sequence is an inhibitor of inflammation.

  2007cites this paper
• Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation.

  2007cites this paper
• Stent-Based Local Delivery of Nuclear Factor-&kgr;B Decoy Attenuates In-Stent Restenosis in Hypercholesterolemic Rabbits

  2006cites this paper
• Angiotensin II Type 1 Receptor Blockade Attenuates In-Stent Restenosis by Inhibiting Inflammation and Progenitor Cells

  2006cites this paper
• A third-generation, long-acting, dihydropyridine calcium antagonist, azelnidipine, attenuates stent-associated neointimal formation in non-human primates

  2006cites this paper
• Essential role of PKC-zeta in normal and angiotensin II-accelerated neointimal growth after vascular injury.

  2006cites this paper
• Chemokines in vascular pathology (review).

  2006cites this paper
• Vascular access in hemodialysis: issues, management, and emerging concepts.

  2005cites this paper
• Gene Transfer of a Broad Spectrum CC-Chemokine Inhibitor Reduces Vein Graft Atherosclerosis in Apolipoprotein E–Knockout Mice

  2005cites this paper
• Angiogenic Factors in Human Atherosclerotic Lesions and Relationship to Intraplaque Angiogenesis

  2005cites this paper
• Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice.

  2005cites this paper
• Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal

  2005cites this paper
• Advances towards Cerebrovascular Gene Therapy

  2005cites this paper
• Endothelial nitric oxide synthase gene transfer restores endothelium–dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E–deficient mice

  2005cites this paper
• Angiotensin II-Induced Progression of Established Atherosclerosis in Monocyte Chemoattractant Protein-1 Is an Essential Inflammatory Mediator in

  2004cites this paper
• Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys

  2004cites this paper
• Gene Transfer of Stromal Cell–Derived Factor-1&agr; Enhances Ischemic Vasculogenesis and Angiogenesis via Vascular Endothelial Growth Factor/Endothelial Nitric Oxide Synthase–Related Pathway: Next-Generation Chemokine Therapy for Therapeutic Neovascularization

  2004cites this paper
• Anti—Monocyte Chemoattractant Protein-1 Gene Therapy Protects against Focal Brain Ischemia in Hypertensive Rats

  2004cites this paper
• Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice.

  2004cites this paper
• Blockade of CCR2 ameliorates progressive fibrosis in kidney.

  2004cites this paper
• Critical Role of Monocyte Chemoattractant Protein-1 Receptor CCR2 on Monocytes in Hypertension-Induced Vascular Inflammation and Remodeling

  2004cites this paper
• Cholesterol-Lowering Independent Regression and Stabilization of Atherosclerotic Lesions by Pravastatin and by Antimonocyte Chemoattractant Protein-1 Therapy in Nonhuman Primates

  2004cites this paper
• Essential Role for Smad3 in Regulating MCP-1 Expression and Vascular Inflammation

  2004cites this paper
• Essential Role of Vascular Endothelial Growth Factor in Angiotensin II–Induced Vascular Inflammation and Remodeling

  2004cites this paper
• Local Endovascular Delivery, Gene Therapy, and Cell Transplantation for Peripheral Arterial Disease

  2004cites this paper
• Inhibition of neointimal hyperplasia after balloon injury by cis-element ‘decoy’ of early growth response gene-1 in hypercholesterolemic rabbits

  2004cites this paper
• Essential Role of Vascular Endothelial Growth Factor and Flt-1 Signals in Neointimal Formation After Periadventitial Injury

  2004cites this paper
• Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis.

  2004cites this paper
• Gene therapy approaches for the prevention of restenosis.

  2004cites this paper
• The HVJ-envelope as an innovative vector system for cardiovascular disease.

  2004cites this paper
• Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis.

  2004cites this paper
• The monocyte: the key in the lock to reduce stent hyperplasia?

  2004cites this paper
• Blockade of Vascular Endothelial Growth Factor Suppresses Experimental Restenosis After Intraluminal Injury by Inhibiting Recruitment of Monocyte Lineage Cells

  2004cites this paper
• Role of macrophages and stellate cells in the pathogenesis of veno-occlusive disease: an electron microscopic case study.

  2003cites this paper
• The Emerging Role of Gene Therapy in the Treatment of Cardiovascular Diseases

  2003cites this paper
• Transfection With a Dominant-Negative Inhibitor of Monocyte Chemoattractant Protein-1 Gene Improves Cardiac Function After 6 Hours of Cold Preservation

  2003cites this paper
• Molecular Mechanisms Mediating Inflammation in Vascular Disease: Special Reference to Monocyte Chemoattractant Protein-1

  2003cites this paper
• Atherosclerosis: cell biology and lipoproteins Oxidizedphospholipids inatherosclerosis Related review: Oxidized phospholipids as modulators of inflammation in atherosclerosis

  2003cites this paper
• Kensuke Egashira to Monocyte Chemoattractant Protein-1 Molecular Mechanisms Mediating Inflammation in Vascular Disease : Special Reference

  2003cites this paper
• Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1–Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells

  2003cites this paper
• Hemodialysis Vascular Access Dysfunction: From Pathophysiology to Novel Therapies

  2003cites this paper
• Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases

  2003cites this paper
• Stress and vascular responses: anti-inflammatory therapeutic strategy against atherosclerosis and restenosis after coronary intervention.

  2003cites this paper
• Elevated Whole-Blood Tissue Factor Procoagulant Activity as a Marker of Restenosis After Percutaneous Transluminal Coronary Angioplasty and Stent Implantation

  2003cites this paper